Prospects of Platelet-Rich Plasma in Regenerative Medicine
Division of Surgery, ICAR-Indian Veterinary Research Institute, Izatnagar, Bareilly, Uttar Pradesh, India
† These authors contributed equally to this work.
Special Issue: Prospects of Platelet Rich Plasma in Regenerative Medicine
Received: May 25, 2023 | Accepted: May 26, 2023 | Published: June 02, 2023
OBM Transplantation 2023, Volume 7, Issue 2, doi:10.21926/obm.transplant.2302187
Recommended citation: Banu SA, Sharun K. Prospects of Platelet-Rich Plasma in Regenerative Medicine. OBM Transplantation 2023; 7(2): 187; doi:10.21926/obm.transplant.2302187.
© 2023 by the authors. This is an open access article distributed under the conditions of the Creative Commons by Attribution License, which permits unrestricted use, distribution, and reproduction in any medium or format, provided the original work is correctly cited.
Regenerative medicine is a rapidly evolving field that aims to replace or regenerate tissues or organs damaged by disease or injury. Platelet-rich plasma (PRP) is an autologous blood product with a high concentration of platelets, growth factors, and other bioactive molecules that can stimulate tissue repair and regeneration. PRP has gained significant attention in regenerative medicine due to its potential to enhance tissue healing and regeneration . In this editorial, we discuss the prospects of PRP in regenerative medicine and highlight recent advancements in its clinical applications. PRP is derived from whole blood by centrifugation or using specific kits, separating the platelet-rich fraction from the other blood components. The concentration of platelets in PRP is typically 3-5 times higher than in whole blood, and it also contains various growth factors, cytokines, and chemokines that can stimulate tissue healing and regeneration [2,3].
The composition of PRP can vary depending on the preparation method, such as the centrifugation speed, duration, and the presence or absence of anticoagulants . Thus, the clinical efficacy of PRP can vary depending on the preparation method, and there is no standardized protocol for PRP preparation. PRP exerts its regenerative effects through several mechanisms. Firstly, platelets release growth factors such as platelet-derived growth factor, transforming growth factor-beta, and vascular endothelial growth factor, which can stimulate cellular proliferation, angiogenesis, and extracellular matrix synthesis. Furthermore, platelets can recruit and activate various immune cells, such as neutrophils, macrophages, and T-cells, enhancing tissue repair and regeneration. In addition, PRP can also modulate the inflammatory response by releasing anti-inflammatory cytokines such as interleukin-10 (IL-10) and downregulating pro-inflammatory cytokines such as tumor necrosis factor-alpha (TNF-α) [5,6].
PRP has been used in various clinical settings, including orthopedics, dermatology, dentistry, and plastic surgery. In orthopedics, PRP has been used to treat musculoskeletal injuries such as tendinopathy, osteoarthritis, and fractures [7,8]. The use of PRP in orthopedics has been supported by several clinical trials, which have demonstrated its efficacy in reducing pain and improving function. In dermatology, PRP has been used for facial rejuvenation, hair loss, and wound healing [9,10]. The use of PRP for facial rejuvenation has gained popularity due to its potential to stimulate collagen synthesis and improve skin texture . Similarly, PRP has been used for hair loss by injecting it into the scalp to stimulate hair follicle growth . A systematic review of PRP for chronic wounds found that PRP was associated with a significant reduction in wound size and healing time compared to standard care . Chronic wounds are a major health problem affecting millions worldwide and can lead to serious complications, such as infections and amputations. PRP has also been used to promote the healing of chronic wounds such as diabetic foot ulcers and venous leg ulcers [14,15].
In dentistry, PRP has been used for implant placement, periodontal surgery, and bone grafting. The use of PRP in dentistry has been supported by several clinical trials, which have demonstrated its efficacy in reducing postoperative pain and inflammation, promoting bone regeneration, and enhancing implant success rates . The use of PRP in regenerative medicine has also shown promising results in treating musculoskeletal injuries, particularly in sports medicine .
Despite the promising results of studies on the use of PRP in regenerative medicine, several challenges still need to be addressed. One major challenge is the lack of standardization in the preparation of PRP. There are currently no established guidelines for the optimal preparation of PRP, and different preparation methods can result in PRP with different concentrations of growth factors and other bioactive molecules [18,19]. This can lead to variability in the efficacy of PRP treatments and difficulties in comparing results between studies. Another challenge is the limited understanding of the mechanisms by which PRP promotes tissue regeneration. While it is clear that PRP contains a wide range of growth factors and other bioactive molecules that can stimulate tissue repair and regeneration, the precise mechanisms by which these molecules act are not yet fully understood . Further research is needed to elucidate the specific biological processes involved in the regenerative effects of PRP.
In brief, using PRP in regenerative medicine is a promising field with significant potential in treating various conditions, from musculoskeletal injuries to chronic wounds. While there are still challenges that need to be addressed, including the lack of standardization in the preparation of PRP and the limited understanding of its mechanisms of action, the growing body of evidence supporting the efficacy of PRP treatments suggests that it has an important role to play in the future of regenerative medicine. The enormous potential of PRP is usually not exploited because it is hardly entirely comprehended. Global efforts are being made to fully explore the potential of PRP. Attaining this might resolve many medical science challenges by paving the way for more sophisticated and reasonably priced therapeutic management techniques. As research in this field continues, it is likely that new applications of PRP in regenerative medicine will be discovered, leading to further improvements in patient outcomes and quality of life.
The authors thank the Director, ICAR-Indian Veterinary Research Institute, Izatnagar, Bareilly, India, and the All-India Network Program on Diagnostic Imaging and Management of Surgical Conditions in Animals (AINP-DIMSCA) for providing the necessary research facilities to carry out this work.
All authors listed have made a substantial, direct, and intellectual contribution to the work and approved it for publication.
No substantial funding is to be stated.
All authors declare that there exist no commercial or financial relationships that could, in any way, lead to a potential conflict of interest.
- Sharun K, Jambagi K, Dhama K, Kumar R, Pawde AM, Amarpal. Therapeutic potential of platelet-rich plasma in canine medicine. Arch Razi Inst. 2021; 76: 721-730.
- Sharun K, Pawde AM, Amarpal. Classification and coding systems for platelet-rich plasma (PRP): A peek into the history. Expert Opin Biol Ther. 2021; 21: 121-123. [CrossRef]
- Sharun K, Pawde AM, Manjusha KM, Banu SA, Kalaiselvan E, Kumar R, et al. Classification and coding of platelet-rich plasma derived from New Zealand white rabbits for tissue engineering and regenerative medicine applications. Expert Opin Biol Ther. 2021; 21: 1473-1482. [CrossRef]
- Dashore S, Chouhan K, Nanda S, Sharma A. Preparation of platelet-rich plasma: National IADVL PRP taskforce recommendations. Indian Dermatol Online J. 2021; 12: S12-S23. [CrossRef]
- Jain NK, Gulati M. Platelet-rich plasma: A healing virtuoso. Blood Res. 2016; 51: 3-5. [CrossRef]
- Sharun K, Chandran D, Manjusha KM, Mankuzhy PD, Kumar R, Pawde AM, et al. Advances and prospects of platelet-rich plasma therapy in veterinary ophthalmology. Vet Res Commun. 2023. doi: 10.1007/s11259-022-10064-z. [CrossRef]
- Sharun K, Pawde AM. Platelet-rich plasma (PRP) for post-traumatic osteoarthritis: Classification and coding systems. Osteoarthr Cartil. 2020; 28: 1581-1582. [CrossRef]
- Sharun K, Pawde AM. Platelet-rich plasma for hip osteoarthritis: Comparing the variables in production protocol and composition. Clin Rheumatol. 2020; 39: 3899-3901. [CrossRef]
- Sharun K, Pawde AM. Platelet-rich plasma for burn wound: Minimum reporting requirements. J Burn Care Res. 2020; 41: 1309. [CrossRef]
- Sharun K, Pawde AM. Minimum requirements for reporting clinical trials evaluating the therapeutic potential of platelet-rich plasma. J Am Acad Dermatol. 2021; 84: e43-e44. [CrossRef]
- Wang JV, Schoenberg E, Saedi N, Ibrahim O. Platelet-rich plasma, collagen peptides, and stem cells for cutaneous rejuvenation. J Clin Aesthet Dermatol. 2020; 13: 44-49.
- Paichitrojjana A, Paichitrojjana A. Platelet rich plasma and its use in hair regrowth: A review. Drug Des Devel Ther. 2022; 16: 635-645. [CrossRef]
- Meznerics FA, Fehérvári P, Dembrovszky F, Kovács KD, Kemény LV, Csupor D, et al. Platelet-rich plasma in chronic wound management: A systematic review and meta-analysis of randomized clinical trials. J Clin Med. 2022; 11: 7532. [CrossRef]
- Elbarbary AH, Hassan HA, Elbendak EA. Autologous platelet-rich plasma injection enhances healing of chronic venous leg ulcer: A prospective randomised study. Int Wound J. 2020; 17: 992-1001. [CrossRef]
- Sharun K, Pawde AM. Autologous platelet-rich plasma for non-ischemic diabetic foot ulcers. Ann Vasc Surg. 2022; 81: e7-e8. [CrossRef]
- Xu J, Gou L, Zhang P, Li H, Qiu S. Platelet-rich plasma and regenerative dentistry. Aust Dent J. 2020; 65: 131-142. [CrossRef]
- Ficek K, Kamiński T, Wach E, Cholewiński J, Cięszczyk P. Application of platelet rich plasma in sports medicine. J Hum Kinet. 2011; 30: 85-97. [CrossRef]
- Everts PA, Knape JT, Weibrich G, Schönberger JP, Hoffmann J, Overdevest EP, et al. Platelet-rich plasma and platelet gel: A review. J Extra Corpor Technol. 2006; 38: 174-187.
- Sharun K, Pawde AM. Variables affecting the potential efficacy of platelet-rich plasma in dermatology. J Am Acad Dermatol. 2021; 84: e47-e48. [CrossRef]
- Anitua E, Prado R, Orive G. Closing regulatory gaps: New ground rules for platelet-rich plasma. Trends Biotechnol. 2015; 33: 492-495. [CrossRef]